| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Altimmune, Inc. | Chief Business Officer | Common Stock, par value $0.0001 | 65,536 | $405,012 | $6.18 | 27 Jan 2026 | Direct |
| Altimmune, Inc. | Chief Business Officer | Restricted Stock Units | 47,550 | 27 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | 31 Jan 2026 | 1 | +$14,033 | 4 | Chief Business Officer | 02 Feb 2026, 16:10 |
| ALT | Altimmune, Inc. | 27 Jan 2026 | 3 | -$26,135 | 4 | Chief Business Officer | 29 Jan 2026, 16:15 |
| ALT | Altimmune, Inc. | 25 Jan 2026 | 3 | -$21,202 | 4 | Chief Business Officer | 27 Jan 2026, 07:10 |
| ALT | Altimmune, Inc. | 01 Jan 2026 | 3 | -$8,935 | 4 | Chief Business Officer | 05 Jan 2026, 16:10 |
| ALT | Altimmune, Inc. | 31 Jul 2025 | 1 | +$4,296 | 4 | Chief Business Officer | 04 Aug 2025, 16:06 |
| ALT | Altimmune, Inc. | 31 Jan 2025 | 1 | +$13,541 | 4 | Chief Business Officer | 03 Feb 2025, 20:45 |
| ALT | Altimmune, Inc. | 25 Jan 2025 | 5 | -$26,957 | 4 | Chief Business Officer | 28 Jan 2025, 21:05 |
| ALT | Altimmune, Inc. | 01 Jan 2025 | 3 | -$17,917 | 4 | Chief Business Officer | 03 Jan 2025, 16:40 |
| ALT | Altimmune, Inc. | 31 Jul 2024 | 1 | +$4,961 | 4 | Chief Business Officer | 01 Aug 2024, 17:43 |
| ALT | Altimmune, Inc. | 31 Jan 2024 | 1 | +$13,531 | 4 | Chief Business Officer | 01 Feb 2024, 18:02 |
| ALT | Altimmune, Inc. | 25 Jan 2024 | 2 | $0 | 4 | Chief Business Officer | 29 Jan 2024, 18:32 |
| ALT | Altimmune, Inc. | 01 Jan 2024 | 3 | -$28,159 | 4 | Chief Business Officer | 04 Jan 2024, 18:00 |
| ALT | Altimmune, Inc. | 31 Jul 2023 | 1 | +$5,148 | 4 | Chief Business Officer | 02 Aug 2023, 17:43 |
| ALT | Altimmune, Inc. | 03 Jan 2023 | 2 | $0 | 4 | Chief Business Officer | 04 Jan 2023, 15:06 |
| ALT | Altimmune, Inc. | 03 Jan 2023 | 0 | $0 | 3 | Chief Business Officer | 04 Jan 2023, 15:05 |